COMMUNIQUÉS West-GlobeNewswire

R1 RCM to Present at the Baird 2019 Global Healthcare Conference
19/08/2019
CHICAGO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]
Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants
19/08/2019
CANTON, Mass., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO) (the “Company”) announced today the completion of its previously announced exchange offer (the “Offer”) and consent [...]
Atrion Corporation Increases Quarterly Cash Dividend by 15%
19/08/2019
ALLEN, Texas, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.35 per share to $1.55 per share. Specifically, the Board of Directors [...]
The Ensign Group Announces Appointment of Chief Financial Officer of The Pennant Group
19/08/2019
SAN JUAN CAPISTRANO, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice [...]
Merus Announces Financial Results for the Second Quarter 2019 and Provides Business Update
19/08/2019
UTRECHT, The Netherlands, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human [...]
Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)
19/08/2019
First New IV and Oral Antibiotic with a Novel Mechanism of Action Approved in Nearly Two Decades Provides Critically Needed Treatment Option for Adult Patients with CABP XENLETA Expected to be Available mid-September [...]
Trading in Coloplast shares by board members, executives or associated persons
19/08/2019
Please see enclosed pdf. Attachment 19082019_trading_in_shares_LRA
Biotricity CEO Waqaas Al-Siddiq in Live Interview on Yahoo Finance
19/08/2019
CEO to Discuss American Insurance and Remote Patient Monitoring Tuesday, August 20 at 11:45am REDWOOD CITY, Calif., Aug. 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), today announced that its CEO and [...]
AB Science annouces the success of a private placement
19/08/2019
AB SCIENCE ANNOUNCES THE SUCCESS OF A PRIVATE PLACEMENT EUR 10.0 million raised through a private placement of 2,463,054 new ordinary shares at a price of EUR 4.06 (with subscription warrants attached, giving the right [...]
CyberFuels Inc. Announces Year-End Results
19/08/2019
PALM BEACH GARDENS, Fla., Aug. 19, 2019 (GLOBE NEWSWIRE) -- EncounterCare Solutions (ECSL: Pink Sheets OTC) posted its year-end results on the OTC on August 15, 2019. Revenue for the year ended June 2019 increased by [...]
Daratumumab Abstracts Selected for Presentation at 17th International Myeloma Workshop
19/08/2019
Media Release Copenhagen, Denmark, August 19, 2019 Thirteen Janssen-sponsored abstracts featuring daratumumab selected for presentation at the 17 th International Myeloma Workshop (IMF) Genmab A/S (Nasdaq: GMAB) [...]
Transactions in relation to share buyback program
19/08/2019
Announcement no. 48/2019 19 August 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Valneva Announces Management Board Stock Purchases
19/08/2019
Saint Herblain (France), August 19, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, announces today that all [...]
Valneva annonce l'acquisition d'actions par son Directoire
19/08/2019
Saint Herblain (France), 19 août 2019 – Valneva SE (“Valneva” ou “le Groupe”), société de biotechnologie développant et commercialisant des vaccins contre des maladies infectieuses générant d’importants besoins médicaux [...]
Kiadis Pharma Announces Investor Events for September 2019
19/08/2019
Company announces Notice of Results for the six months ended June 30, 2019 Amsterdam, The Netherlands, August 19, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS) , a [...]
Share buy-back week 33/2019
19/08/2019
Announcement 19 August 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
Sanofi: information concerning the total number of voting rights and shares, July 2019
19/08/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, juillet 2019
19/08/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
PRA Health Sciences Announces Strategic Alliance between Symphony Health and Close-Up International
19/08/2019
RALEIGH, N.C., Aug. 19, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, the company’s data solutions division, has expanded its global data services by entering into a [...]

Pages